Elizabeth Awo-Ejeh, a 29-year-old undergraduate, was diagnosed with breast cancer when she was 25. The dark, beautiful young lady had been married for two years, and was looking forward to building a ...

Medicus Pharma offers high-risk, high-reward potential, with its novel SkinJect patch for basal cell carcinoma and Antev ...

The study will use a companion lipid biomarker test to identify those with a poor prognosis who are potential best responders.

The report provides a detailed analysis of the current marketed drugs and late-stage pipeline drugs. BROOKLYN, NY, UNITED ...

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) is among the best growth stocks to invest in for the next 5 years. During the ...

Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen ...

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...

An announcement from RedHill Biopharma ( ($RDHL) ) is now available. On July 1, 2025, RedHill Biopharma announced the initiation of patient ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

BerGenBio, reeling from the failure of its lead cancer drug, has opted to merge with fellow Norwegian cancer biotech Oncoinvent.

An expert highlights that the future of metastatic castration-resistant prostate cancer (mCRPC) treatment is advancing with novel drug classes such as radioligand therapies, proteolysis-targeting ...

Researchers at Columbia University have discovered that metformin, a well-known diabetes drug, may play an important role in ...